+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Periodontal Therapeutics Market 2019-2023 - Product Image

Global Periodontal Therapeutics Market 2019-2023

  • ID: 4774805
  • Report
  • June 2019
  • Region: Global
  • 123 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 3M Co.
  • Den-Mat Holdings LLC
  • MORE
Periodontal diseases are prevalent in both developed and developing countries across the world. The disease affects individuals regardless of their age and has become one of the growing public health concerns. The disease is common among individuals in developing countries compared to developed countries. Globally, it is posing as one of the most common oral conditions in human being. The rising prevalence of periodontal diseases across the world will increase the demand for periodontal drugs and subsequently drive the growth of the global periodontal therapeutics market size at a CAGR of over 6% during the forecast period.

Market Overview

Changing lifestyle

Poor oral hygiene, stress, diabetes, smoking, and other age-related risk factors are some of the negative aspects of a fast-changing lifestyle. These factors increase the probability of the onset of periodontal diseases. This is expected to have a positive impact on the growth of the global periodontal therapeutics market size.

Lack of awareness about disease symptoms and cure

There is a delay in the diagnosis and treatment for periodontal disease due to the lack of awareness about the symptoms associated with periodontal diseases. Despite its high prevalence, only a small proportion of the affected population seek medical treatment. This is expected to hinder the growth of the market during the forecast period.

Competitive Landscape

The market appears to be moderately concentrated with few players occupying the market share. Companies such as 3M Co. and Bausch Health Companies Inc. have intensified competition. Factors such as the growing prevalence of periodontal diseases and the changing lifestyle of people will provide significant growth opportunities for periodontal therapeutics companies. 3M Co., Bausch Health Companies Inc., Den-Mat Holdings LLC, Kaken Pharmaceuticals Co. Ltd., and Teva Pharmaceutical Industries Ltd. are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Co.
  • Den-Mat Holdings LLC
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Local antibiotics - Market size and forecast 2018-2023
  • Systemic antibiotics - Market size and forecast 2018-2023
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • 3M Co.
  • Bausch Health Companies, Inc.
  • Den-Mat Holdings LLC
  • Kaken Pharmaceuticals Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits:
Exhibit 01: Global oral hygiene products market
Exhibit 02: Segments of global oral hygiene products market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Pipeline landscape for periodontal diseases
Exhibit 18: Some of the key clinical trials for periodontal diseases
Exhibit 19: Product - Market share 2018-2023 (%)
Exhibit 20: Comparison by product
Exhibit 21: Local antibiotics - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Local antibiotics - Year-over-year growth 2019-2023 (%)
Exhibit 23: Systemic antibiotics - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Systemic antibiotics - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Top 3 countries in North America
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: Top 3 countries in Europe
Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 37: Top 3 countries in Asia
Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 40: Top 3 countries in ROW
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Risk factors for periodontal diseases
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Percent of periodontal disease with age
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: 3M Co. - Vendor overview
Exhibit 52: 3M Co. - Business segments
Exhibit 53: 3M Co. - Organizational developments
Exhibit 54: 3M Co. - Geographic focus
Exhibit 55: 3M Co. - Segment focus
Exhibit 56: 3M Co. - Key offerings
Exhibit 57: 3M Co. - Key customers
Exhibit 58: Bausch Health Companies Inc. - Vendor overview
Exhibit 59: Bausch Health Companies Inc. - Product segments
Exhibit 60: Bausch Health Companies Inc. - Organizational developments
Exhibit 61: Bausch Health Companies Inc. - Geographic focus
Exhibit 62: Bausch Health Companies Inc. - Segment focus
Exhibit 63: Bausch Health Companies Inc. - Key offerings
Exhibit 64: Bausch Health Companies Inc. - Key customers
Exhibit 65: Den-Mat Holdings LLC - Vendor overview
Exhibit 66: Den-Mat Holdings LLC - Business segments
Exhibit 67: Den-Mat Holdings LLC - Organizational developments
Exhibit 68: Den-Mat Holdings LLC - Key offerings
Exhibit 69: Den-Mat Holdings LLC - Key customers
Exhibit 70: Kaken Pharmaceuticals Co. Ltd. - Vendor overview
Exhibit 71: Kaken Pharmaceuticals Co. Ltd. - Business segments
Exhibit 72: Kaken Pharmaceuticals Co. Ltd. - Organizational developments
Exhibit 73: Kaken Pharmaceuticals Co. Ltd. - Segment focus
Exhibit 74: Kaken Pharmaceuticals Co. Ltd. - Key offerings
Exhibit 75: Kaken Pharmaceuticals Co. Ltd. - Key customers
Exhibit 76: Teva Pharmaceutical Industries Ltd. - Vendor overview
Exhibit 77: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 78: Teva Pharmaceutical Industries Ltd. - Organizational developments
Exhibit 79: Teva Pharmaceutical Industries Ltd. - Geographic focus
Exhibit 80: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibit 81: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 82: Teva Pharmaceutical Industries Ltd. - Key customers
Exhibit 83: Validation techniques employed for market sizing
Exhibit 84: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • 3M Co.
  • Den-Mat Holdings LLC
  • MORE
The following companies are recognised as the key players in the global periodontal therapeutics market: 3M Co., Bausch Health Companies Inc., Den-Mat Holdings LLC, Kaken Pharmaceuticals Co. Ltd., and Teva Pharmaceutical Industries Ltd.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the growing geriatric population.”

According to the report, one of the major drivers for this market is the growing risk factors due to changing lifestyle.

Further, the report states that one of the major factors hindering the growth of this market is the lack of awareness about disease symptoms and cure.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • 3M Co.
  • Bausch Health Companies Inc.
  • Den-Mat Holdings LLC
  • Kaken Pharmaceuticals Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll